BDNF and major depressive disorder: Given the above, BDNF has been proposed as a potential MDD biomarker, postulating that the measurement of its peripheral levels, as well as the polymorphism and methylation status of the genes that encode it, could be used as predictors of disease severity or response to treatment or to evaluate the course of the illness [2].